Literature DB >> 22345581

Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia.

Kimberly D McCarthy1, Kevin P Cain, Kevin L Winthrop, Nibondh Udomsantisuk, Nguyen T N Lan, Borann Sar, Michael E Kimerling, Nong Kanara, Lut Lynen, Patama Monkongdee, Theerawit Tasaneeyapan, Jay K Varma.   

Abstract

RATIONALE: Although nontuberculous mycobacteria (NTM) are widely documented as a cause of illness among HIV-infected people in the developed world, studies describing the prevalence of NTM disease among HIV-infected people in most resource-limited settings are rare.
OBJECTIVES: To evaluate the prevalence of mycobacterial disease in HIV-infected patients in Southeast Asia.
METHODS: We enrolled people with HIV from three countries in Southeast Asia and collected pulmonary and extrapulmonary specimens to evaluate the prevalence of mycobacterial disease. We adapted American Thoracic Society/Infectious Disease Society of America guidelines to classify patients into NTM pulmonary disease, NTM pulmonary disease suspects, NTM disseminated disease, and no NTM categories.
MEASUREMENTS AND MAIN RESULTS: In Cambodia, where solid media alone was used, NTM was rare. Of 1,060 patients enrolled in Thailand and Vietnam, where liquid culture was performed, 124 (12%) had tuberculosis and 218 (21%) had NTM. Of 218 patients with NTM, 66 (30%) were classified as NTM pulmonary disease suspects, 9 (4%) with NTM pulmonary disease, and 10 (5%) with NTM disseminated disease. The prevalence of NTM disease was 2% (19 of 1,060). Of 51 patients receiving antiretroviral therapy (ART), none had NTM disease compared with 19 (2%) of 1,009 not receiving ART.
CONCLUSIONS: Although people with HIV frequently have sputum cultures positive for NTM, few meet a strict case definition for NTM disease. Consistent with previous studies, ART was associated with lower odds of having NTM disease. Further studies of NTM in HIV-infected individuals in tuberculosis-endemic countries are needed to develop and validate case definitions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345581     DOI: 10.1164/rccm.201107-1327OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in Cambodia.

Authors:  S C Auld; B K Moore; R P Kyle; B Eng; K Nong; E S Pevzner; K K Eam; M T Eang; W P Killam
Journal:  Public Health Action       Date:  2016-06-21

Review 3.  Nontuberculous mycobacteria infections in immunosuppressed hosts.

Authors:  Emily Henkle; Kevin L Winthrop
Journal:  Clin Chest Med       Date:  2014-12-23       Impact factor: 2.878

4.  Comparison of Mycobacterium tuberculosis complex Yield and Contamination Rates using Lowenstein-Jensen with and without Antibiotics in Western Kenya.

Authors:  A Okumu; K McCarthy; J Orwa; J Williamson; S Musau; H Alexander; S Cavanaugh; S Modi; K Cain
Journal:  J Med Sci Clin Res       Date:  2017

5.  Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.

Authors:  Anne F Luetkemeyer; Michelle A Kendall; Xingye Wu; Maria Cristina Lourenço; Ute Jentsch; Susan Swindells; Sarojini S Qasba; Jorge Sanchez; Diane V Havlir; Beatriz Grinsztejn; Ian M Sanne; Cynthia Firnhaber
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

6.  Prevalence of non-tuberculous mycobacteria in HIV-infected patients admitted to hospital with pneumonia.

Authors:  N C Lapinel; S E Jolley; J Ali; D A Welsh
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

7.  Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.

Authors:  Willy Ssengooba; Sebastian J Gelderbloem; Gerald Mboowa; Anne Wajja; Carolyn Namaganda; Philippa Musoke; Harriet Mayanja-Kizza; Moses Lutaakome Joloba
Journal:  Health Res Policy Syst       Date:  2015-01-15

8.  Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.

Authors:  Clare L van Halsema; Violet N Chihota; Nicolaas C Gey van Pittius; Katherine L Fielding; James J Lewis; Paul D van Helden; Gavin J Churchyard; Alison D Grant
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

9.  Species diversity of non-tuberculous mycobacteria isolated from humans, livestock and wildlife in the Serengeti ecosystem, Tanzania.

Authors:  Bugwesa Z Katale; Erasto V Mbugi; Louise Botha; Julius D Keyyu; Sharon Kendall; Hazel M Dockrell; Anita L Michel; Rudovick R Kazwala; Mark M Rweyemamu; Paul van Helden; Mecky I Matee
Journal:  BMC Infect Dis       Date:  2014-11-18       Impact factor: 3.090

10.  An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.

Authors:  Willy Ssengooba; David P Kateete; Anne Wajja; Eric Bugumirwa; Gerald Mboowa; Carolyn Namaganda; Germine Nakayita; Maria Nassolo; Francis Mumbowa; Benon B Asiimwe; James Waako; Suzanne Verver; Philippa Musoke; Harriet Mayanja-Kizza; Moses L Joloba
Journal:  Tuberc Res Treat       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.